Jinthe Van Loenhout

986 citations

16 papers · 803 indexed · h-index 11

Radiology, Nuclear Medicine and Imaging top 5%
- Plasma Applications and Diagnostics 3
Immunology
- Immunotherapy and Immune Responses 4
- Phagocytosis and Immune Regulation 3
Oncology
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 2
Surfaces, Coatings and Films
Cancer Research
Biomedical Engineering
- Nanoplatforms for cancer theranostics 5
Molecular Biology
- Heme Oxygenase-1 and Carbon Monoxide 4
- RNA modifications and cancer 2

Co-authors: Evelien Smits Annemie Bogaerts Christophe Deben Marc Peeters Abraham Lin Wilma Van Boxem Joey De Backer Jorrit De Waele
Cited by: Radiology, Nuclear Medicine and Imaging Immunology Oncology
Journals: Cancers (3 papers)Cells (2 papers)Antioxidants (2 papers)
Partner nations: Belgium Australia Germany

In The Last Decade

Jinthe Van Loenhout

16 papers receiving 800 citations

Peers

Countries citing papers authored by Jinthe Van Loenhout

Since Specialization

Citations

This map shows the geographic impact of Jinthe Van Loenhout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinthe Van Loenhout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinthe Van Loenhout more than expected).

Fields of papers citing papers by Jinthe Van Loenhout

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinthe Van Loenhout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinthe Van Loenhout. The network helps show where Jinthe Van Loenhout may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jinthe Van Loenhout, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jinthe Van Loenhout Line = papers co-authored together Jinthe Van Loenhout links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers Antioxidants ·Laurie Freire Boullosa,Jinthe Van Loenhout,Tal Flieswasser,Christophe Hermans,Céline Merlin,D. G. Hershan,Elly Marcq,Marlies Verschuuren,Winnok H. De Vos,Filip Lardon,Evelien Smits,Christophe Deben	2023	16
2	Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model Pharmaceutics ·Laurie Freire Boullosa,Jinthe Van Loenhout,Christophe Hermans,D. G. Hershan,Céline Merlin,Elly Marcq,Rosana Carneiro Tavares,Wim Martinet,Guido R.Y. De Meyer,Filip Lardon,Evelien Smits,Christophe Deben	2022	7
3	Co-Targeting the EGFR and PI3K/Akt Pathway to Overcome Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma: What about Autophagy? Cancers ·Martin Essomba,Jinthe Van Loenhout,Marc Peeters,Jan B. Vermorken,Filip Lardon,An Wouters	2022	6
4	Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer Redox Biology ·Laurie Freire Boullosa,Jinthe Van Loenhout,Tal Flieswasser,Jorrit De Waele,Christophe Hermans,Hilde Lambrechts,Bart Cuypers,Kris Laukens,Esther Bartholomeus,Vasiliki Siozopoulou,Winnok H. De Vos,Marc Peeters,Evelien Smits,Christophe Deben	2021	85
5	Auranofin and Cold Atmospheric Plasma Synergize to Trigger Distinct Cell Death Mechanisms and Immunogenic Responses in Glioblastoma Cells ·Jinthe Van Loenhout,Laurie Freire Boullosa,Delphine Quatannens,Jorrit De Waele,Céline Merlin,Hilde Lambrechts,D. G. Hershan,Christophe Hermans,Abraham Lin,Filip Lardon,Marc Peeters,Annemie Bogaerts,Evelien Smits,Christophe Deben	2021	56
6	Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment Clinical & Translational Immunology ·Jonas R.M. Van Audenaerde,Elly Marcq,Bianca von Scheidt,賢太郎上田,Amanda J. Oliver,Jorrit De Waele,Delphine Quatannens,Jinthe Van Loenhout,Patrick Pauwels,Geert Roeyen,Filip Lardon,Clare Y. Slaney,Marc Peeters,Michael H. Kershaw,Phillip K. Darcy,Evelien Smits	2020	28
7	Oxidative Stress-Inducing Anticancer Therapies: Taking a Closer Look at Their Immunomodulating Effects Antioxidants ·Jinthe Van Loenhout,Marc Peeters,Annemie Bogaerts,Evelien Smits,Christophe Deben	2020	77
8	Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer Cells ·Tal Flieswasser,Jinthe Van Loenhout,Laurie Freire Boullosa,Atıf EVREN,Jorrit De Waele,Jonas R.M. Van Audenaerde,Filip Lardon,Evelien Smits,Patrick Pauwels,Julie Jacobs	2020	41
9	The Influence of Cell Type and Culture Medium on Determining Cancer Selectivity of Cold Atmospheric Plasma Treatment Cancers ·Ramesh Pudi,Abraham Lin,Wilma Van Boxem,Jinthe Van Loenhout,Joey De Backer,Christophe Deben,Sylvia Dewilde,Evelien Smits,Annemie Bogaerts	2019	89
10	Building a Bridge between Chemotherapy and Immunotherapy in Malignant Pleural Mesothelioma: Investigating the Effect of Chemotherapy on Immune Checkpoint Expression International Journal of Molecular Sciences ·Elly Marcq,Jonas R.M. Van Audenaerde,Jorrit De Waele,Julie Jacobs,Jinthe Van Loenhout,Jmfj Silveira,Patrick Pauwels,Jan P. van Meerbeeck,Evelien Smits	2019	10
11	Non‐Thermal Plasma as a Unique Delivery System of Short‐Lived Reactive Oxygen and Nitrogen Species for Immunogenic Cell Death in Melanoma Cells Advanced Science ·Abraham Lin,Yury Gorbanev,Joey De Backer,Jinthe Van Loenhout,Wilma Van Boxem,Filip Lemière,Paul Cos,Sylvia Dewilde,Evelien Smits,Annemie Bogaerts	2019	203
12	Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells Cancers ·Jinthe Van Loenhout,Tal Flieswasser,Laurie Freire Boullosa,Jorrit De Waele,Jonas R.M. Van Audenaerde,Elly Marcq,Julie Jacobs,Abraham Lin,Eva Lion,Heleen Dewitte,Marc Peeters,Sylvia Dewilde,Filip Lardon,Annemie Bogaerts,Christophe Deben,Evelien Smits	2019	89
13	Immunogenic Potential Of Cold Atmospheric Plasma For The Treatment Of Pancreatic Cancer VUBIR (Vrije Universiteit Brussel) ·Jinthe Van Loenhout,Christophe Deben,Julie Jacobs,Jorrit De Waele,Jonas R.M. Van Audenaerde,Elly Marcq,Sylvia Dewilde,Annemie Bogaerts,Evelien Smits	2018	3
14	PO-419 Poly(I:C) prepares glioblastoma cells for anti-PD-L1 therapy via lymphocyte attraction and activation in a TLR3-dependent manner ESMO Open ·Jorrit De Waele,Elly Marcq,Jonas R.M. Van Audenaerde,Jinthe Van Loenhout,Christophe Deben,Patrick Pauwels,Filip Lardon,Marc Peeters,An Wouters,Evelien Smits	2018	1
15	Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade OncoImmunology ·Jorrit De Waele,Elly Marcq,Jonas R.M. Van Audenaerde,Jinthe Van Loenhout,Christophe Deben,Karen Zwaenepoel,Erik Van de Kelft,Mats Anthony Baker Nordbø,Tomas Menovsky,R Steidl,Yannick Willemen,Patrick Pauwels,Zwi Berneman,Filip Lardon,Marc Peeters,An Wouters,Evelien Smits	2017	36
16	Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells Oncotarget ·Jonas R.M. Van Audenaerde,Jorrit De Waele,Elly Marcq,Jinthe Van Loenhout,Eva Lion,Abdelhalli Khezzar,Ralf Jesenofsky,Atsushi Masamune,Geert Roeyen,Patrick Pauwels,Filip Lardon,Marc Peeters,Evelien Smits	2017	56

About Jinthe Van Loenhout

Jinthe Van Loenhout is a scholar working on Immunology, Oncology and Microbiology, having authored 16 papers that have together received 803 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (5 papers), Heme Oxygenase-1 and Carbon Monoxide (4 papers), Immunotherapy and Immune Responses (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Phagocytosis and Immune Regulation (3 papers), Plasma Applications and Diagnostics (3 papers), RNA modifications and cancer (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (296 citations), Immunology (177 citations) and Oncology (205 citations). Jinthe Van Loenhout has collaborated with scholars based in Belgium, Australia and Germany. Frequent co-authors include Evelien Smits, Annemie Bogaerts, Christophe Deben, Marc Peeters, Abraham Lin, Wilma Van Boxem, Joey De Backer, Jorrit De Waele, Sylvia Dewilde and Filip Lardon. Their work appears in journals such as Cancers, Cells, Antioxidants, Oncotarget and OncoImmunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact